𝔖 Bobbio Scriptorium
✦   LIBER   ✦

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

✍ Scribed by Robert Lafyatis; Eugene Kissin; Michael York; Giuseppina Farina; Kerry Viger; Marvin J. Fritzler; Peter A. Merkel; Robert W. Simms

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
188 KB
Volume
60
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Reconstitution of peripheral blood B cel
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis
✍ Maria J. Leandro; Geraldine Cambridge; Michael R. Ehrenstein; Jonathan C. W. Edw πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 2 views

## Abstract ## Objective To study the quantitative and phenotypic reconstitution of peripheral blood B cells and its relationship to the dynamics of clinical response in patients with rheumatoid arthritis (RA) following B cell depletion with rituximab. ## Methods Twenty‐four patients with active

Elevated serum BAFF levels in patients w
Elevated serum BAFF levels in patients with systemic sclerosis: Enhanced BAFF signaling in systemic sclerosis B lymphocytes
✍ Takashi Matsushita; Minoru Hasegawa; Koichi Yanaba; Masanari Kodera; Kazuhiko Ta πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 167 KB πŸ‘ 1 views

## Abstract ## Objective To determine serum levels of BAFF, a potent B cell survival factor, in patients with systemic sclerosis (SSc) and relate the results to the clinical features of SSc. ## Methods Serum BAFF levels in 83 patients with SSc were examined by enzyme‐linked immunosorbent assay (

Lymphokine-activated killer cell and nat
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis
✍ Thomas V. Kantor; Theresa L. Whiteside; Diana Friberg; Robert B. Buckingham; Tho πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 499 KB πŸ‘ 2 views

Objective. To determine the ability of T lymphocytes and natural killer (NK) cells from patients with systemic sclerosis (SSc) to respond to cytokines and to generate immune effector cells. Methods. The numbers and percentages of peripheral blood T and NK cells were examined by 2-color flow cytometr